Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.65 |
| ▸ | CA2 | P00918 | 2/20 | 0.65 |
| ▸ | CA7 | P43166 | 2/20 | 0.65 |
| ▸ | CA9 | Q16790 | 2/20 | 0.65 |
| ▸ | CA12 | O43570 | 1/20 | 0.65 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.65 |
| ▸ | NOS3 | P29474 | 2/20 | 0.56 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.56 |
| ▸ | HTR3B | O95264 | 1/20 | 0.56 |
| ▸ | HTR3A | P46098 | 1/20 | 0.56 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.56 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4392260 | 0.90 | CA4 (0.59) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1405603 | 0.82 | CA1 (0.65) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1405602 | 0.82 | CA1 (0.65) | CA1CA2CA7CA9CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL8489 | 0.80 | CA1 (1.00) | CA1CA2CA7CA9CA12 | |
| 1,4-Dimethoxybenzene SCHEMBL21802643 | 0.80 | CA1 (1.00) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1366759 | 0.80 | CA1 (0.61) | CA1CA2CA7CA9CA12 | |
| SCHEMBL13185916 | 0.78 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL156005 | 0.78 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL66886 | 0.78 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL10895835 | 0.78 | CA1 (0.58) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12020872-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | Ambient Photonics, Inc. (US) | 2024-06-25 | — | — | US | claimed |
| EP-4240797-A1 | COMBINATION OF SPECIFIC ANNELLATED NAPHTHOPYRANE ISOMERS | Rodenstock GmbH (DE) | 2023-09-13 | — | — | EP | claimed |
| WO-2023135127-A1 | COMBINATION OF SPECIFIC ANNELLATED NAPHTHOPYRANE ISOMERS | RODENSTOCK GMBH (DE) | 2023-07-20 | — | — | WO | claimed |
| US-11664171-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | Ambient Photonics, Inc. (US) | 2023-05-30 | — | — | US | claimed |
| US-20230154691-A1 | Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes | Ambient Photonics, Inc. (US) | 2023-05-18 | — | — | US | claimed |
| US-11286233-B2 | Stilbene derivatives for the treatment of CNS and other disorders | Ambient Photonics, Inc. (US) | 2022-03-29 | — | — | US | claimed |
| EP-3807258-B1 | PHOTOCHROMIC ANNELATED NAPHTHOPYRANE SYSTEMS WITH SPECIAL SUBSTITUENTS, FOR ATTAINING RAPID LIGHTENING SPEEDS | RODENSTOCK GMBH (DE) | 2021-10-20 | — | — | EP | claimed |
| US-20210114976-A1 | Stilbene Derivatives for the Treatment of CNS and Other Disorders | Ambient Photonics, Inc. (US) | 2021-04-22 | — | — | US | claimed |
| US-20210082632-A1 | Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes | Ambient Photonics, Inc. (US) | 2021-03-18 | — | — | US | claimed |
| EP-3621945-A1 | STILBENE DERIVATIVES FOR THE TREATMENT OF CNS AND OTHER DISORDERS | Ambient Photonics, Inc. (US) | 2020-03-18 | — | — | EP | claimed |
| US-7534853-B2 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2009-05-19 | — | — | US | claimed |
| US-7094897-B2 | Rhodium and iridium complexes | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2006-08-22 | — | — | US | claimed |
| US-20060065890-A1 | Rhodium and iridium complexes | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2006-03-30 | — | — | US | claimed |
| EP-1379534-B1 | RHODIUM AND IRIDIUM COMPLEXES | COVION ORGANIC SEMICONDUCTORS (DE) | 2004-12-15 | — | — | EP | claimed |
| US-20040133004-A1 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2004-07-08 | — | — | US | claimed |
| EP-1379534-A1 | RHODIUM AND IRIDIUM COMPLEXES | Covion Organic Semiconductors GmbH (DE) | 2004-01-14 | — | — | EP | claimed |
| WO-2002081488-A1 | RHODIUM AND IRIDIUM COMPLEXES | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2002-10-17 | — | — | WO | claimed |
| EP-0469889-B1 | (p-Carbonylaminophenyl)-sulphonyl-nitromethane derivatives | ZENECA LTD (GB) | 1996-01-17 | — | — | EP | claimed |
| US-5189031-A | Inhibitor of enzyme aldose reductase, useful in the treatment of certain peripheral effects of diabetes and galactosemia | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-02-23 | — | — | US | claimed |
| EP-0469889-A1 | (p-Carbonylaminophenyl)-sulphonyl-nitromethane derivatives | ZENECA LIMITED (GB) | 1992-02-05 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210114976-A1 | Stilbene Derivatives for the Treatment of CNS and Other Disorders | CLN6, MAPT, PSEN2 | CA1 4265/4885CA2 4340/4885CA7 4680/4885 |
| US-11286233-B2 | Stilbene derivatives for the treatment of CNS and other disorders | CLN6, MAPT, PSEN2 | CA1 4265/4885CA2 4340/4885CA7 4680/4885 |
| US-12020872-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | FDFT1, SUN2, CDC73 | CA1 4332/4885CA2 3904/4885CA7 1919/4885 |
| US-20230154691-A1 | Stilbene and Fused Stilbene Derivatives as Solar Cell Dyes | FDFT1, SUN2, CDC73 | CA1 4332/4885CA2 3904/4885CA7 1919/4885 |
| US-20060065890-A1 | Rhodium and iridium complexes | RPIA, INPP5B, SIRT5 | CA1 1991/4885CA2 369/4885CA7 683/4885 |
| US-20040133004-A1 | Rhodium and iridium complexes | RPIA, SIRT5, INPP5B | CA1 2352/4885CA2 415/4885CA7 862/4885 |
| US-11664171-B2 | Stilbene and fused stilbene derivatives as solar cell dyes | SUN2, FDFT1, SIK1 | CA1 4381/4885CA2 3642/4885CA7 2853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.